A carregar...
Pre-treatment or Post-treatment of Human Glioma Cells With BIX01294, the Inhibitor of Histone Methyltransferase G9a, Sensitizes Cells to Temozolomide
Glioblastoma (GBM) is a malignant, primary brain tumor, highly resistant to conventional therapies. Temozolomide (TMZ) is a first line therapeutic agent in GBM patients, however, survival of such patients is poor. High level of DNA repair protein, O(6)-methylguanine-DNA-methyltransferase (MGMT) and...
Na minha lista:
| Publicado no: | Front Pharmacol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6224489/ https://ncbi.nlm.nih.gov/pubmed/30450051 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2018.01271 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|